Glenmede Trust CO Na Corbus Pharmaceuticals Holdings, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $353 - $710	-376 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $1,034 - $1,812	216 Added 135.0%	376 $3,000
Q2 2018 Aug 15, 2018	BUY	$5.05 - $6.8 $808 - $1,088	160 New	160 $1,000
Q4 2017 Feb 15, 2018	SELL	$6.6 - $7.78 $1,056 - $1,244	-160 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $920 - $1,240	160	160 $0

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.